DiaMedica Therapeutics Inc.
(DMAC - NASDAQ)
7,94 USD
📋 Profilo Aziendale

DiaMedica Therapeutics Inc. operates as a clinical-stage biopharmaceutical entity dedicated to advancing therapeutic solutions for neurological and renal disorders.

|